Specifically, hypermethylation of the IL-15 promoter region was shown to prevent the binding of the transcriptional repressor Zeb1, increasing the transcription of IL-15 and subsequently initiating CTCL pathogenesis (8). This evidence concerns the gene IL15 and primary cutaneous T-cell non-Hodgkin lymphoma.